The 9th World Orphan Drug Congress is not an event to be missed.
The Congress was one of the first events to bring together the full range of stakeholders and influencers in the orphan drug and rare disease sector, from the pharma and biotechs to patient advocates and representatives from payers.
It continues to be a key meeting for the sector in pushing forward with strategy, advocacy and partnering within the rare disease space.
Now recognised as the largest and most established European orphan drug event, we are once again proud to deliver another fantastic speaker line up and content filled agenda that represents the whole orphan drug scene.
The 9th annual event will address the strategic and commercial aspects of bringing new treatments to patients who suffer from rare diseases.
For 2018 we will be expanding the meeting further in our new Eastern European setting, offering more dedicated content and tracks than ever before on Clinical Development, Market Access, Science & Strategy, Pitch & Partner and Cell & Gene Therapy.
We thank our Advisory Board members for their contribution to the agenda in 2017, and look forward to working together to make 2018 even more successful.